Alaron 10 mg Tablet (Loratadine) – ACI Limited

1. About Alaron (Loratadine)

Alaron 10 mg Tablet contains Loratadine, a second-generation, long-acting, non-sedating antihistamine manufactured by ACI Limited, Bangladesh. Loratadine selectively antagonizes peripheral H1 histamine receptors, providing effective relief from allergic symptoms without causing the drowsiness associated with first-generation antihistamines like chlorphenamine or diphenhydramine.

Loratadine is one of the most widely used antihistamines globally and is included on the WHO Model List of Essential Medicines. Its once-daily dosing, excellent safety profile, and minimal CNS effects make it suitable for a broad patient population including adults, elderly, diabetic patients, and those requiring mental alertness throughout the day. ACI Limited's Alaron brand makes this essential medicine widely available at an affordable price across Bangladesh.

2. Mechanism of Action

Loratadine is a selective, long-acting antagonist of peripheral histamine H1 receptors. When allergens (pollen, dust, animal dander, food, drugs) trigger an immune response, mast cells and basophils release histamine. Histamine binds to H1 receptors on blood vessel endothelium, smooth muscle, and sensory nerve endings, causing vasodilation, increased vascular permeability, bronchoconstriction, and the characteristic symptoms of allergy (itching, sneezing, watery eyes, rhinorrhea, urticaria).

Loratadine competitively and reversibly blocks H1 receptors, preventing histamine from producing these effects. Unlike first-generation antihistamines, loratadine is lipophobically — it does not readily cross the blood-brain barrier at therapeutic doses, resulting in significantly lower rates of sedation. Loratadine also has mild anti-inflammatory properties through inhibition of the release of inflammatory mediators from mast cells.

3. Indications

Alaron 10 mg (Loratadine) is indicated for:

• Allergic Rhinitis (Seasonal — Hay Fever): Relief of sneezing, rhinorrhea, nasal itching, and nasal congestion caused by pollen, grass, mould, or other seasonal allergens
• Perennial Allergic Rhinitis: Year-round nasal symptoms caused by house dust mites, pet dander, cockroaches, and indoor moulds
• Chronic Idiopathic Urticaria (CIU): Relief of itching and reduction of hives (wheals) in chronic urticaria of unknown cause — a particularly important indication
• Allergic Skin Reactions: Pruritus (itching), urticaria, angioedema, and other IgE-mediated allergic skin manifestations
• Allergic Conjunctivitis: Itching, redness, and tearing of the eyes associated with allergic conditions
• Insect Bite Reactions: Local allergic reactions to mosquito, bee, or other insect bites
• Food Allergy Reactions: Mild-to-moderate allergic reactions — as part of a management plan; anaphylaxis requires adrenaline

Loratadine does not treat the underlying allergy or provide emergency treatment for anaphylaxis — for severe allergic reactions, adrenaline (epinephrine) is the first-line emergency treatment.

4. Dosage and Administration

Adults and children ≥12 years:

• 10 mg (1 tablet) once daily
• With or without food
• Same time each day for consistent blood levels

Children 6–12 years (≥30 kg body weight):

• 10 mg (1 tablet) once daily

Children 2–5 years or 6–12 years (<30 kg):

• Loratadine syrup/suspension (5 mg/5 mL) 5 mg once daily — tablet form not appropriate for young children

Elderly: No dose adjustment required; excellent tolerability.

Hepatic impairment: In severe hepatic impairment, start with 10 mg every other day as clearance is reduced.

Renal impairment: In severe renal impairment (GFR <30 mL/min), start with 10 mg every other day.

Duration: For seasonal allergic rhinitis — use during the allergy season or as long as needed for symptom control. For urticaria — until symptom resolution. Loratadine can be used long-term without tolerance development.

5. Contraindications

• Known hypersensitivity to loratadine or any ingredient in the formulation
• Children under 2 years — insufficient safety data; use loratadine-specific pediatric formulations under specialist guidance only

Loratadine has very few contraindications and is generally well-tolerated across diverse patient populations.

6. Warnings and Precautions

Driving and Machinery: Though non-sedating at standard doses, individual responses vary. Some patients may experience mild drowsiness, especially at initiation. Caution is advised until the patient's response to loratadine is established. Alcohol may potentiate sedation.

Diabetes and Loratadine: Loratadine does not interfere with blood glucose control and has no significant interactions with common diabetes medications (metformin, sulphonylureas, DPP-4 inhibitors, GLP-1 agonists, insulin). It is one of the safest antihistamine choices for diabetic patients requiring allergy relief. Notably, some first-generation antihistamines (e.g., chlorphenamine, promethazine) can mask hypoglycemia symptoms — loratadine does not have this concern.

Hepatic Impairment: Loratadine is metabolized by CYP3A4 and CYP2D6 in the liver. Patients with significant liver disease may have increased loratadine exposure; consider alternate-day dosing in severe hepatic impairment.

Not a Bronchodilator: Loratadine does not provide bronchodilation and should not be used as primary treatment for asthma attacks. For allergic asthma, it may help prevent allergic triggers but bronchodilators (salbutamol, ipratropium) and inhaled corticosteroids remain the primary treatments.

Pregnancy and Lactation: Loratadine is generally considered safe in pregnancy (extensive post-marketing data shows no increased fetal risk). It is excreted in breast milk — use with caution in breastfeeding; cetirizine is sometimes preferred as it has more safety data in this context. Consult a doctor.

7. Side Effects

Common (1–10%):

• Headache
• Fatigue or drowsiness (less common than with first-generation antihistamines)
• Dry mouth (less frequent than first-generation antihistamines)
• Nausea

Uncommon:

• Dizziness
• Palpitations, tachycardia
• Gastrointestinal upset

Rare:

• Skin reactions: rash, pruritus (itching paradox)
• Elevated liver enzymes (isolated reports)
• Hypersensitivity reactions

Overall, loratadine has one of the best tolerability profiles among all antihistamines. Sedation rates in clinical trials are comparable to placebo in most patients.

8. Drug Interactions

Loratadine has relatively few clinically significant drug interactions:

• CYP3A4/CYP2D6 inhibitors (ketoconazole, erythromycin, cimetidine): May increase loratadine plasma concentrations; however, clinical significance is low as loratadine's therapeutic window is wide and it remains non-sedating even at higher plasma levels
• Alcohol: May enhance CNS depressant effects; avoid alcohol during treatment
• MAO inhibitors: Avoid concurrent use — potential for additive effects
• No significant interactions with common diabetes medications (metformin, sulphonylureas, insulin, GLP-1 agonists, SGLT2 inhibitors)
• No significant interactions with common antihypertensives (ACE inhibitors, ARBs, CCBs, beta-blockers)

9. Pharmacokinetics

Absorption: Well absorbed after oral administration. Tmax ~1–2 hours. Food increases AUC by ~40% and delays Tmax; clinical significance is minimal.

Metabolism: Extensively metabolized by hepatic CYP3A4 and CYP2D6 to its active metabolite desloratadine (also marketed separately as a drug). Desloratadine accounts for much of the continued antihistamine activity and has a longer half-life than the parent compound.

Distribution: High plasma protein binding (~97% for loratadine; ~73% for desloratadine). Does not significantly penetrate the blood-brain barrier at therapeutic doses — basis for the non-sedating profile.

Elimination: Approximately equal excretion via urine and feces as metabolites. Terminal half-life of loratadine ~8 hours; desloratadine ~27 hours — combined activity lasts up to 24 hours, supporting once-daily dosing.

10. Loratadine vs First-Generation Antihistamines

Alaron (Loratadine) represents a significant clinical advantage over older antihistamines:

• Non-sedating: Does not cause significant drowsiness at therapeutic doses — safe for daytime use, driving, and occupational activities
• Once-daily dosing: 10 mg once per day vs multiple daily doses for older antihistamines
• Minimal anticholinergic effects: No significant dry mouth, urinary retention, constipation, or blurred vision — important for elderly and diabetic patients
• No tolerance development: Maintains efficacy on long-term use without dose escalation
• No effect on cardiac conduction: Unlike some antihistamines (e.g., terfenadine, astemizole), loratadine does not prolong QT interval at recommended doses
• Suitable for diabetic patients: Does not mask hypoglycemia symptoms or affect glycemic control

11. Allergy and Diabetes — Clinical Relevance

Allergic conditions are common in Bangladesh's urban and peri-urban diabetic population due to air quality, dust mite exposure, and changing environmental conditions. For diabetic patients with allergies:

• Loratadine is the safest antihistamine choice — no interaction with glycemic control or diabetes medications
• First-generation antihistamines (e.g., chlorphenamine) may cause sedation and confusion that can mimic hypoglycemia in elderly diabetic patients
• Allergic rhinitis can worsen sleep quality, increasing insulin resistance — effective treatment improves overall metabolic status
• Diabetic patients on multiple medications benefit from loratadine's minimal drug interaction profile

12. ACI Limited — Quality Assurance

Alaron is produced by ACI Limited, one of Bangladesh's leading WHO-GMP certified pharmaceutical companies. ACI's commitment to quality manufacturing ensures consistent tablet dissolution, potency, and bioavailability across all batches of Alaron, delivering reliable antihistamine efficacy comparable to the innovator product.

13. Storage

• Store below 30°C in a cool, dry place
• Keep away from direct sunlight, heat, and moisture
• Keep out of reach of children
• Do not use after expiry date on blister/box
• Keep in original blister packaging until use

Frequently Asked Questions (FAQ)

Q1: What is Alaron 10 mg (Loratadine) used for?

Alaron 10 mg tablet contains Loratadine, a non-sedating antihistamine used to relieve allergy symptoms including: sneezing, runny or blocked nose, and itchy eyes from hay fever or year-round allergies (allergic rhinitis); itchy skin rashes and hives (urticaria); itching from insect bites or mild food allergic reactions; and allergic skin conditions. It works by blocking histamine receptors to prevent the body's exaggerated immune response to allergens. One tablet once daily provides 24-hour relief.

Q2: Is Alaron (Loratadine) safe for diabetic patients?

Yes — Loratadine (Alaron) is considered one of the safest antihistamine options for diabetic patients. It has no significant interaction with common diabetes medications including metformin, sulphonylureas (glipizide, gliclazide), DPP-4 inhibitors, GLP-1 agonists, SGLT2 inhibitors, or insulin. Unlike older antihistamines, loratadine does not cause sedation that could be confused with hypoglycemia, does not affect blood glucose levels, and does not cause the anticholinergic effects (dry mouth, constipation, urinary problems) that are particularly problematic in elderly diabetic patients.

Q3: Will Alaron make me sleepy?

Alaron (Loratadine) is specifically classified as a non-sedating antihistamine. In clinical trials, sedation rates were no different from placebo in most patients. The vast majority of patients can take Alaron and drive, operate machinery, and work normally. However, as with any medication, a small number of individuals may experience mild drowsiness — if this occurs, avoid activities requiring full alertness until you know how you respond. Alcohol may increase sedation — avoid alcohol while taking Alaron.

Q4: How quickly does Alaron work and how long does it last?

Alaron (Loratadine) begins working within 1–3 hours of taking the tablet. Peak antihistamine effect is reached within 1–2 hours. The effects last for 24 hours, which is why once-daily dosing is sufficient. For best results in seasonal allergic rhinitis, consider starting treatment a few days before the allergy season begins to establish consistent blood levels before allergen exposure peaks. Do not take more than one 10 mg tablet in 24 hours.